The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
D-Dimer Levels and Risk of Recurrent Venous Thromboembolism
Abstract
CONTEXT: Widespread screening of patients with venous thromboembolism (VTE) for thrombophilic risk factors has become common clinical practice. Because of the increasing number of risk factors, assessing the risk of recurrence in an individual patient is intricate; therefore, a laboratory method that measures multifactorial thrombophilia is required. OBJECTIVE: To prospectively study the relationship between the risk of recurrent VTE and D-dimer, a global marker of coagulation activation and fibrinolysis. DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort study of 610 patients older than 18 years who were treated with oral anticoagulants for at least 3 months with a first spontaneous VTE, in whom D-dimer levels were measured shortly after discontinuation of oral anticoagulation. The study was conducted at the Department of Internal Medicine I, University Hospital, Vienna, Austria. Patients entered the study at time of discontinuation of oral anticoagulants and were observed at 3-month intervals during the first year and every 6 months thereafter from July 1992 to October 2002. MAIN OUTCOME MEASURE: Objectively documented symptomatic recurrent VTE. RESULTS: A total of 79 (13%) of 610 patients had recurrent VTE with a mean observation time of 38 months. Patients with recurrence had significantly higher D-dimer levels compared with those without recurrence (553 ng/mL vs 427 ng/mL, P =.01). Compared with patients with D-dimer levels of 750 ng/mL or higher, the relative risk (RR) of recurrence was 0.6 (95% confidence interval [CI], 0.3-1.4), 0.6 (95% CI, 0.3-1.2), and 0.3 (95% CI, 0.1-0.6) in patients with D-dimer levels of 500 to 749 ng/mL, 250 to 499 ng/mL, and less than 250 ng/mL, respectively. The cumulative probability of recurrent VTE at 2 years was 3.7% (95% CI, 0.9%-6.5%) among patients with D-dimer levels of less than 250 ng/mL compared with 11.5% (95% CI, 8.0%-15.0%) among patients with higher levels (P =.001). Patients with D-dimer levels of less than 250 ng/mL had a 60% lower RR of recurrence compared with patients with higher levels (RR, 0.4; 95% CI, 0.2-0.8). CONCLUSION: Patients with a first spontaneous VTE and a D-dimer level of less than 250 ng/mL after withdrawal of oral anticoagulation have a low risk of VTE recurrence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Poort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
The Statistical Analysis of Failure Time Data
Klein, J. P. (1982) · Technometrics · doi:10.1080/00401706.1982.10487769 · Cited by 2,215
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism
Kyrle, P. A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K., & Eichinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430702 · Cited by 763 · cited 2×
“Thestudyendpointwasrecurrent symptomatic deep vein thrombosis or recurrent symptomatic pulmonary embolism, confirmed by venography, color duplex sonography (in case of proximal vein thrombosis of the contralateral leg), ventilation-perfusion scanning, and/or spiral computed tomography.(10)”
BackgroundMethodSelf-citationThree Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
Agnelli, G., Prandoni, P., Santamaria, M. G., Bagatella, P., Iorio, A., Bazzan, M., Moia, M., Guazzaloca, G., Bertoldi, A., Tomasi, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450302 · Cited by 591
De Stefano, V., Martinelli, I., Mannucci, P. M., Paciaroni, K., Chiusolo, P., Casorelli, I., Rossi, E., & Leone, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411104 · Cited by 482
Pinede, L., Ninet, J., Duhaut, P., Chabaud, S., Demolombe-Rague, S., Durieu, I., Nony, P., Sanson, C., & Boissel, J.-P. (2001) · Circulation · doi:10.1161/01.cir.103.20.2453 · Cited by 408
Legnani, C., Cosmi, B., Guazzaloca, G., Pancani, C., Coccheri, S., & Palareti, G. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612936 · Cited by 291
Risk Factors in Venous Thromboembolism
Martinelli, I. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616237 · Cited by 291
Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism.
Eichinger, S., Stümpflen, A., Hirschl, M., Bialonczyk, C., Herkner, K. R., STAIN, M., Schneider, B., Pabinger, I., Lechner, K., & Kyrle, P. A. (1998) · PubMed · Cited by 250
Self-citationFibrin fragment D-dimer and the risk of future venous thrombosis
Cushman, M., Folsom, A. R., Wang, L., Aleksic, N., Rosamond, W. D., Tracy, R. P., & Heckbert, S. R. (2003) · Blood · doi:10.1182/blood-2002-05-1416 · Cited by 231
Schulman, S., Sten-Linder, M., Wiman, B., Egberg, N., Johnsson, H., Lindmarker, P., & and the DURAC Trial Study Group (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614554 · Cited by 212
The Thrombophilias: Well-Defined Risk Factors with Uncertain Therapeutic Implications
Bauer, K. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-5-200109040-00013 · Cited by 193
How we diagnose and treat deep vein thrombosis
Hirsh, J., & Lee, A. Y. Y. (2002) · Blood · doi:10.1182/blood.v99.9.3102 · Cited by 179
Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Mannhalter, C., Stümpflen, A., Schneider, B., Lechner, K., Kyrle, P. A., & Eichinger, S. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614409 · Cited by 131
Self-citationCoexistence of Factor V Leiden and Factor II A20210 Mutations and Recurrent Venous Thromboembolism
D’Andrea, G., Colaizzo, D., Cappucci, G., del Popolo, A., Brancaccio, V., Ciampa, A., Grandone, E., Minno, G. D., & Margaglione, M. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614882 · Cited by 116
Stefano, V. D., Martinelli, I., Mannucci, P. M., Paciaroni, K., Rossi, E., Chiusolo, P., Casorelli, I., & Leone, G. G. M. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02827.x · Cited by 90
Eichinger, S., Weltermann, A., Mannhalter, C., Minar, E., Bialonczyk, C., Hirschl, M., Schönauer, V., Lechner, K., & Kyrle, P. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.20.2357 · Cited by 83
Self-citationD-Dimer as a Risk Factor for Deep Vein Thrombosis: The Leiden Thrombophilia Study
Andreescu, A. C. M., Rosendaal, F. R., & Cushman, M. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612942 · Cited by 80
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
“54,56 Elevated D-dimer levels, either during or after discontinuation of anticoagulation, indicate an increasedriskofrecurrence; 61–63 ontheotherhand,singlethrombo- philicdefectshavealowpredictivevalueandanticoagulationmanage-ment based on thrombophilia testing has not been found to reduce VTE…”
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Metadata
- Authors
- Eichinger, S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-08-27
- Volume
- 290
- Issue
- 8
- Pages
- 1071
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2014569258
- Cited by
- 327
- References
- 23
- FWCI
- 13.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.